A case of mucosa-associated lymphoid tissue lymphoma with penicillin allergy successfully treated with levofloxacin, minomycin and rabeprazole

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 10, 2010, Pages 1961-1964

  Konno, Tomoko ^a   Motoori, Shigeatsu ^a   Iwamoto, Nozomi ^a   Miyazawa, Tomoe ^a   Saito, Shigeyo ^a   Kitagawa, Naoko ^a   Saisho, Hiromitsu ^a   Furuse, Junji ^b   Itabashi, Masayuki ^c  

^a Kaken Hospital   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c International University of Health and Welfare Mita Hospital   (Japan)

Author keywords

Levofloxacin; MALT lymphoma; Minomycin

Indexed keywords

CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; MINOCYCLINE; RABEPRAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CANCER PATIENT; CASE REPORT; DRUG TOLERABILITY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PENICILLIN ALLERGY; STOMACH MUCOSA;

EID: 79960763953     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Helicobacter Res 12(6): 392-398, 2008.
2. Helicobacter Res 5(3): 242-245, 2001.
3. Ellman MH, Hurwitz H, Thomas C, et al: Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18(11): 1741-1743, 1991.
4. Lim IG and Bertouch JV: Remission of lymphoma after drug withdrawal in rheumatoid arthritis. Med J Aust 177(9): 500-501, 2002. (Pubitemid 35373438)
5. Murakami K, Sato R, Okimoto T, et al: Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection. J Gastroenterol Hepatol 21(1 Pt 2): 262-267, 2006.
6. Di Mario F, Cavallaro LG and Scarpignato C: 'Rescue' therapies for the management of Helicobacter pylori infection. Dig Dis 24(1-2): 113-130, 2006.
7. Kobayashi I, Murakami K, Kato M, et al: Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005. J Clin Microbiol 45(12): 4006-4010, 2007.
8. Helicobacter Res 12(5): 346-348, 2008.
9. Gisbert JP, Pérez-Aisa A, Castro-Fernández M, et al: Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin. Dig Liver Dis 42(4): 287-290, 2010.
10. Murakami K, Sato R, Okimoto T, et al: Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance. Aliment Pharmacol Ther 17(1): 119-123, 2003. (Pubitemid 36140441)
11. Helicobacter Res 11(4): 399-402, 2007.
12. Helicobacter pylori 44(7): 480-482, 2003.
13. Igari J, Oguri T and Higuchi T: Evaluation of minocycline and cefuzonam for antimicrobial activity against clinical isolates. Jpn J Antibiot 47(8): 1013-1029, 1994. (Pubitemid 24275299)
14. Sánchez JE. Sáenz NG, Rincón MR, et al: Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones. J Antimicrob Chemother 46(2): 283-285, 2000.
15. Miyachi H, Miki I, Aoyama N, et al: Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan. Helicobacter 11(4): 243-249, 2006. (Pubitemid 44051350)
16. Gatta L, Zullo A, Perna F, et al: A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses. Aliment Pharmacol Ther 22(1): 45-49, 2005. (Pubitemid 40943874)